Get started
Author

Maurice P Dahdaleh

Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines
2019 · B. Yamout, M. Sahraian, et al. · Multiple Sclerosis and Related Disorders · 100
Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelines
2024 · B. Yamout, M. Al-Jumah, et al. · Multiple Sclerosis and Related Disorders · 63
Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks
2016 · Raed Alroughani, Ayse Altintas, et al. · Multiple Sclerosis International · 44
PDF
Functional clinical outcomes in multiple sclerosis: Current status and future prospects
2015 · Rana Karabudak, Maurice Dahdaleh, et al. · Multiple Sclerosis and Related Disorders · 37
Consensus recommendations for the diagnosis and treatment of multiple sclerosis: the Middle East North Africa Committee for Treatment and Research In Multiple Sclerosis (MENACTRIMS)
2015 · B. Yamout, R. Alroughani, et al. · Current Medical Research and Opinion · 36
MENACTRIMS practice guideline for COVID-19 vaccination in patients with multiple sclerosis
2021 · Bassem I Yamout, Magd Zakaria, et al. · Multiple Sclerosis and Related Disorders · 33
PDF
Consensus guidelines for the diagnosis and treatment of multiple sclerosis
2013 · B. Yamout, R. Alroughani, et al. · Current Medical Research and Opinion · 25
Future of Management of Multiple Sclerosis in the Middle East: A Consensus View from Specialists in Ten Countries
2013 · Mohammed Aljumah, Raed Alroughani, et al. · Multiple Sclerosis International · 21
PDF
Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region
2013 · Abdulrahman M. Al Tahan, Isa Alsharoqi, et al. · International Journal of Neuroscience · 15
The importance of quality-of-life assessment in the management of patients with multiple sclerosis. Recommendations from the Middle East MS Advisory Group
2011 · AbdelRahman M. Al-Tahan, Mohammed A. Al-Jumah, et al. · Neurosciences · 14
PDF
Biosimilars: opinion of an expert panel in the Middle East
2008 · S. Bohlega, S. Al-Shammri, et al. · Current Medical Research and Opinion · 13
Adherence to Disease-Modifying Drugs in Patients with Multiple Sclerosis: A Consensus Statement from the Middle East MS Advisory Group
2010 · Bassem I. Yamout, Maurice Dahdaleh, et al. · International Journal of Neuroscience · 12
Will New Injection Devices for Interferon Beta-1a s.c. Affect Treatment Adherence in Patients With Multiple Sclerosis? An Expert Opinion in the Middle East
2011 · Dirk Deleu, Issa Alsharoqi, et al. · International Journal of Neuroscience · 7
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring
2014 · Raed A Alroughani, Hany M Aref, et al. · BMC Neurology · 6
PDF
Multiple sclerosis in the Levant: a regional consensus statement
2013 · Bassem Yamout, Khalid El-Salem, et al. · International Journal of Neuroscience · 6
Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?
2016 · Maurice Dahdaleh, Raed Alroughani, et al. · International Journal of Neuroscience · 4
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring
2014 · R. Alroughani, H. Aref, et al. · Multiple Sclerosis and Related Disorders · 1
Adoption of the 2024 McDonald Diagnostic Criteria for Multiple Sclerosis in the MENA Region: Awareness, Barriers, and Readiness among Neurologists
2026 · Maya Zeineddine, Magd Zakaria, et al. · Multiple Sclerosis and Related Disorders
Works count: 19
Citation count: 437
H-index: 12
I10-index: 12
Year
Topic
Type